A structural biologist's view of the oestrogen receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 74, Issue 5, 2000, Pages 261-268

  Pike, Ashley C W ^a   Brzozowski, Andrzej M ^a   Hubbard, Roderick E ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Agonism; Antagonism; Coactivator; Crystal structure; Oestrogen receptor

Indexed keywords

ANTIESTROGEN; CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PEPTIDE FRAGMENT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

AGONIST; CONFERENCE PAPER; CRYSTAL STRUCTURE; DIMERIZATION; DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN DNA BINDING; PROTEIN DOMAIN; RECEPTOR BLOCKING;

BINDING SITES; DIMERIZATION; HUMANS; LIGANDS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRANSCRIPTION FACTORS;

EID: 0034735850     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00102-3     Document Type: Conference Paper

References (28)

1. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
2. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
3. Nuclear receptor coregulators: Cellular and molecular biology
4. Crystal-structure of the ligand-binding domain of the human nuclear receptor RXR-α
5. Ligand-binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
6. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
7. A structural role for hormone in the thyroid hormone receptor
8. Molecular basis of agonism and antagonism in the oestrogen receptor
9. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
10. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
11. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
12. Atomic structure of progesterone complexed with its receptor
13. Structure and specificity of nuclear receptor-coactivator interactions
14. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and full antagonist
15. A canonical structure for the ligand-binding domain of nuclear receptors
16. The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerisation with ERα in vivo and in vitro
17. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
18. Ligand binding was acquired during the evolution of nuclear receptors
19. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
20. Comparison of the ligand binding specificity and transcript tissue distribution of the estrogen receptors α and β
21. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
22. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
23. Molecular determinants of the estrogen receptor-coactivator interface
24. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
25. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2
26. Determinants of coactivator LxxLL motif specificity in nuclear receptor transcriptional activation
27. Coactivator peptides have a differential stabilising effect on the binding of estrogens and antiestrogens with the estrogen receptor
28. Molecular determinants of tissue selectivity in estrogen receptor modulators